Because elevated prolactin levels are a risk factor for insulin resistance and glucose abnormalities [48], a stronger effect of metformin on glucose homeostasis markers in individuals with prolactin excess [26] may be explained by differences in post-treatment prolactin levels. The gene discussed is PRL; the disease is Increased circulating prolactin concentration.